Clinical Evidence

Our clinical programs are leading the field

Explore the scientific evidence supporting GRAIL’s multi-cancer early detection approach, including peer-reviewed publications and presentations at leading medical congresses. Together, these data highlight test performance, clinical utility, and progress toward transforming cancer screening.

Manuscripts

Journal of Medical Screening

Strong association between reduction of late-stage cancers and reduction of cancer-specific mortality in meta-regression of randomized screening trials across multiple cancer types

View Manuscript
Cancer Letter

Prognostic Implication of Methylation-Based Circulating Tumor DNA Detection Prior to Surgery in Stage I Non-Small Cell Lung Cancer

View Manuscript
Computerized Medical Imaging and Graphics

Enhancing cancer prediction in challenging screen-detected incident lung nodules using time-series deep learning

View Manuscript
NPJ Precision Oncology

A multi-cancer early detection blood test using machine learning detects early-stage cancers lacking USPSTF-recommended screening

View Manuscript
Social Science & Medicine

Attitudes to multi-cancer early detection (MCED) blood tests for population-based screening: A qualitative study in Great Britain

View Manuscript
J Epidemiol Community Health

Impact of screening participation on modelled mortality benefits of a multi-cancer early detection test by socioeconomic group in England

View Manuscript